Post by DEMO Pharmaceuticals S.A.

Current geopolitical developments are driving Europe towards strategic autonomy and safeguarding it against future health crises. In this new landscape, the Greek pharmaceutical industry already covers over 10% of off-patent medicines in the EU, proving our country's dynamic potential. DEMO actively supports this effort by implementing an extensive investment programme in the production of active pharmaceutical ingredients (APIs) and finished pharmaceutical products. In doing so, we ensure the self-sufficiency of Greece and the EU in medicines, while securing their uninterrupted supply. Read more:  https://bit.ly/4ukyHCq #DEMOSA #AlwaysForward